Review of current vaccine development platform to prevent coronavirus disease
Authors:
- 1 September 2022
- journal article
- review article
- Published by Medknow in National Journal of Maxillofacial Surgery
- Vol. 13 (3) , 337-346
Abstract
On January 30, 2020, the World Health Organization (WHO) declared a severe respiratory disorder syndrome which originated in Wuhan city as a global public health emergency, and the pandemic declaration by the WHO was made on March 11, 2020. Persons infected with SARS-CoV-2 are frequently asymptomatic, yet they have high respiratory viral loads, and they are major purveyors of viral spread. These factors have led to the current explosion of COVID-19 hospitalizations and deaths. Vaccines could play an important role by preventing severe diseases and increasing population immunity and reducing the ongoing health crisis. There is wealth of information for the review available since it is a current topic of interest. Initially, Google Scholar was utilized to take an initial sample of what types of articles are available. We searched other databases such as PubMed, EMBASE, and COCHRANE LIBRARY for research articles published up to March 2021, with no language restrictions. We found seven peer-reviewed publications available on the efficacy of SARS-CoV-2 vaccines: AZD1222 (AstraZeneca/University of Oxford), a ChAdOx1-based vaccine with a reported efficacy of 70.4% and two mRNA-based vaccines: BNT162b2 (Pfizer/BioNTech) with a reported efficacy of 95% and mRNA-1273 (Moderna/NIAID) with a reported efficacy of 94.1%. Internet was used as a source because of its limitless networking of resources. Sources used from the internet were written by professionals in their fields and published on reliable sites, in referred publications, or on professional organization sites. The cited references were within the last 2 years.Keywords
This publication has 14 references indexed in Scilit:
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- A New Vaccine to Battle Covid-19New England Journal of Medicine, 2021
- COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategiesEuropean Journal of Pharmacology, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsNew England Journal of Medicine, 2020
- An update on the global vaccine development for coronavirusDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- A systematic review of SARS-CoV-2 vaccine candidatesSignal Transduction and Targeted Therapy, 2020
- Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)Toxicologic Pathology, 2020
- Vaccine Against Covid-19 Disease – Present Status of DevelopmentIndian Journal of Pediatrics, 2020